ArticleCancer2025

Cognitive impairment in patients with melanoma before adjuvant immune checkpoint inhibitor therapy and associations with brain gray matter, catechol-O-methyltransferase genotype, and psychological factors.

Josefine T Danielsen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.